161 related articles for article (PubMed ID: 37265428)
1. Forkhead Box Q1 is a novel regulator of autophagy in breast cancer cells.
Kim SH; Hahm ER; Singh SV
Mol Carcinog; 2023 Oct; 62(10):1449-1459. PubMed ID: 37265428
[TBL] [Abstract][Full Text] [Related]
2. Novel mechanistic targets of forkhead box Q1 transcription factor in human breast cancer cells.
Kim SH; Hahm ER; Singh KB; Singh SV
Mol Carcinog; 2020 Oct; 59(10):1116-1128. PubMed ID: 32754922
[TBL] [Abstract][Full Text] [Related]
3. The FoxQ1 transcription factor is a novel regulator of electron transport chain complex I subunits in human breast cancer cells.
Kim SH; Singh SV
Mol Carcinog; 2022 Mar; 61(3):372-381. PubMed ID: 34939230
[TBL] [Abstract][Full Text] [Related]
4. The Role of Forkhead Box Q1 Transcription Factor in Anticancer Effects of Withaferin A in Breast Cancer.
Kim SH; Singh KB; Hahm ER; Singh SV
Cancer Prev Res (Phila); 2021 Apr; 14(4):421-432. PubMed ID: 33509807
[TBL] [Abstract][Full Text] [Related]
5. Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.
Kim SH; Kaschula CH; Priedigkeit N; Lee AV; Singh SV
J Biol Chem; 2016 Jun; 291(26):13495-508. PubMed ID: 27129776
[TBL] [Abstract][Full Text] [Related]
6. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis.
Zhang H; Meng F; Liu G; Zhang B; Zhu J; Wu F; Ethier SP; Miller F; Wu G
Cancer Res; 2011 Feb; 71(4):1292-301. PubMed ID: 21285253
[TBL] [Abstract][Full Text] [Related]
7. Monocarboxylate transporter 1 is a novel target for breast cancer stem like-cell inhibition by diallyl trisulfide.
Kim SH; Singh SV
Mol Carcinog; 2022 Aug; 61(8):752-763. PubMed ID: 35512572
[TBL] [Abstract][Full Text] [Related]
8. Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells.
Sehrawat A; Kim SH; Vogt A; Singh SV
Carcinogenesis; 2013 Apr; 34(4):864-73. PubMed ID: 23276794
[TBL] [Abstract][Full Text] [Related]
9. The role of forkhead box Q1 transcription factor in ovarian epithelial carcinomas.
Gao M; Shih IeM; Wang TL
Int J Mol Sci; 2012 Oct; 13(11):13881-93. PubMed ID: 23203039
[TBL] [Abstract][Full Text] [Related]
10. Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression.
Xia L; Huang W; Tian D; Zhang L; Qi X; Chen Z; Shang X; Nie Y; Wu K
Hepatology; 2014 Mar; 59(3):958-73. PubMed ID: 24005989
[TBL] [Abstract][Full Text] [Related]
11. Forkhead factor FOXQ1 promotes TGF-β1 expression and induces epithelial-mesenchymal transition.
Fan DM; Feng XS; Qi PW; Chen YW
Mol Cell Biochem; 2014 Dec; 397(1-2):179-86. PubMed ID: 25287361
[TBL] [Abstract][Full Text] [Related]
12. FOXQ1 promotes gastric cancer metastasis through upregulation of Snail.
Zhang J; Liu Y; Zhang J; Cui X; Li G; Wang J; Ren H; Zhang Y
Oncol Rep; 2016 Jun; 35(6):3607-13. PubMed ID: 27109028
[TBL] [Abstract][Full Text] [Related]
13. FOXQ1 regulates epithelial-mesenchymal transition in human cancers.
Qiao Y; Jiang X; Lee ST; Karuturi RK; Hooi SC; Yu Q
Cancer Res; 2011 Apr; 71(8):3076-86. PubMed ID: 21346143
[TBL] [Abstract][Full Text] [Related]
14. Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
Zhang M; Xu Q; Yan S; Li Z; Yan W; Jia X
Oncol Rep; 2016 May; 35(5):3106-14. PubMed ID: 26935526
[TBL] [Abstract][Full Text] [Related]
15. Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity.
Feng J; Xu L; Ni S; Gu J; Zhu H; Wang H; Zhang S; Zhang W; Huang J
Oncotarget; 2014 Oct; 5(20):9689-702. PubMed ID: 25356753
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness.
Kang LJ; Yu ZH; Cai J; He R; Lu JT; Hou C; Wang QS; Li XQ; Zhang R; Feng YM
FASEB J; 2019 May; 33(5):6564-6573. PubMed ID: 30807702
[TBL] [Abstract][Full Text] [Related]
17. [miRNA-96-5p inhibits the proliferation and migration of gastric cancer cells by targeting FoxQ1].
Yang XY; Li N; Deng WY; Ma YJ; Han XL; Zhang ZY; Xie JL; Luo SX
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):193-199. PubMed ID: 30917455
[No Abstract] [Full Text] [Related]
18. FOXQ1 mediates the crosstalk between TGF-β and Wnt signaling pathways in the progression of colorectal cancer.
Peng X; Luo Z; Kang Q; Deng D; Wang Q; Peng H; Wang S; Wei Z
Cancer Biol Ther; 2015; 16(7):1099-109. PubMed ID: 25955104
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of FOXQ1 induces apoptosis and suppresses proliferation in prostate cancer cells by controlling BCL11A/MDM2 expression.
Zhang X; Wang L; Wang Y; Shi S; Zhu H; Xiao F; Yang J; Yang A; Hao X
Oncol Rep; 2016 Oct; 36(4):2349-56. PubMed ID: 27573292
[TBL] [Abstract][Full Text] [Related]
20. FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth.
Kaneda H; Arao T; Tanaka K; Tamura D; Aomatsu K; Kudo K; Sakai K; De Velasco MA; Matsumoto K; Fujita Y; Yamada Y; Tsurutani J; Okamoto I; Nakagawa K; Nishio K
Cancer Res; 2010 Mar; 70(5):2053-63. PubMed ID: 20145154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
